1. Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin

   • Katherine Cox
   • Merhawit Ghebrehiwet
   • Matt Vassar

   Systematic Review 10 January 2023 Pages: 85 - 95

   

2. Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies

   • S Sajith Kumar
   • Bhavani Shankara Bagepally
   • Akhil Sasidharan

   Systematic Review 09 January 2023 Pages: 97 - 108

   

3. Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis

   • Nadine Wentzell
   • Bianca Kollhorst
   • Ulrike Haug

   Original Research Article Open access 21 December 2022 Pages: 109 - 117

   

4. Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus

   • Leona Plum-Mörschel
   • Lizette Ravn Andersen
   • Hanne Haahr

   Original Research Article Open access 11 January 2023 Pages: 119 - 127

   

5. Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System

   • Toru Ogura
   • Chihiro Shiraishi

   Original Research Article 13 January 2023 Pages: 129 - 140

   

6. Assessment of Hormonal Contraceptive Utilization and Associated Odds of Hypercoagulopathy in Patients with Venous Malformations Using a National Claims Database

   • Jami Wang
   • Mollie F. Qian
   • Joyce M. C. Teng

   Short Communication 10 January 2023 Pages: 141 - 145

   

7. Comment on: “Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”

   • Deep Dutta
   • Ritin Mohindra
   • Anoop Misra

   Letter to the Editor 13 January 2023 Pages: 147 - 148

8. Response to Comment on: “Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”

   • Devarapalli Ranjani Durga
   • Nadella Mounika
   • Ramu Adela

   Letter to the Editor 12 January 2023 Pages: 149 - 150

9. Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece

   • George Gourzoulidis
   • Maria Koulentaki
   • Georgia Kourlaba

   Correction 29 December 2022 Pages: 151 - 151

10. Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends

    • Arnaldo Figueiredo
    • Luís Costa
    • Carlos Martins-da-Silva

    Correction Open access 27 January 2023 Pages: 153 - 154